Fund Holdings — Versant Venture Management, LLC

Total Portfolio Value:
$141.41M
Total Bought:
$27.50M
Total Sold:
$16.40M
Net Transaction:
+$11.10M
Notable People:
Brian G. Atwood, Samuel D. Colella, Bradley J. Bolzon, Ross A. Jaffe, William J. Link, Barbara N. Lubash, Donald B. Milder, Kirk G. Nielsen, Robin L. Praeger, Charles M. Warden, Brian G. Atwood, Bradley J. Bolzon, Samuel D. Colella, Ross A. Jaffe, William J. Link, Barbara N. Lubash, Donald B. Milder, Charles M. Warden, Brian G. Atwood, Bradley J. Bolzon, Samuel D. Colella, Ross A. Jaffe, William J. Link, Barbara N. Lubash, Donald B. Milder, Robin L. Praeger, Charles M. Warden, Brian G. Atwood, Bradley J. Bolzon, Samuel D. Colella, Ross A. Jaffe, William J. Link, Kirk G. Nielsen, Robin L. Praeger, Charles M. Warden, Robin L. Praeger, Robin L. Praeger, Thomas F. Woiwode, Samuel D. Colella, William J. Link, Kirk G. Nielsen, Bradley J. Bolzon, Thomas F. Woiwode, Thomas F. Woiwode, Bradley J. Bolzon, Robin L. Praeger, Kirk G. Nielsen, Thomas F. Woiwode, Versant Ventures Vi Gp-, Versant Venture, Versant Ventures Vii Gp-, Versant Vantage I Gp-Gp,, Bradley J. Bolzon, Jerel Clayton Davis, Robin L. Praeger, Thomas F. Woiwode, Clare Ozawa, Clare Ozawa, Thomas F. Woiwode, Robin L. Praeger, Jerel Clayton Davis, Bradley J. Bolzon, Versant Ventures Vi Gp,, Jerel Clayton Davis, Jerel Clayton Davis, Clare Ozawa, Jerel Clayton Davis, Clare Ozawa, Alexander Volker Mayweg, Alexander Volker Mayweg, Versant Vantage Ii Gp-Gp,, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Robin L. Praeger, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Ventures Viii Gp-, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Robin L. Praeger, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Ventures Viii Gp-, Versant Voyageurs Ii Gp-, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Robin L. Praeger, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Voyageurs Ii Gp-, Versant Vantage Iii Gp-Gp,, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Ventures Ix Gp-, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Voyageurs Iii Gp-, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Vantage Iii Gp-Gp,, Versant Ventures Ix Gp-, Versant Voyageurs Iii Gp-, Carlo Dante Rizzuto, Carlo Dante Rizzuto, Carlo Dante Rizzuto, Carlo Dante Rizzuto
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Monte Rosa Therapeutics, Inc.(GLUE)4,382,6873,180,780-1,201,907$68.72M$52.32M37.00%-$16.40M
Century Therapeutics, Inc.(IPSC)012,166,109+12,166,109$0$27.50M19.44%+$27.50M
LENZ Therapeutics, Inc.(LENZ)2,656,8882,656,8880$42.51M$24.31M17.19%-$18.20M
Jade Biosciences, Inc.1,525,8201,525,8200$23.54M$21.44M15.16%-$2.11M
Contineum Therapeutics, Inc.(CTNM)542,628542,6280$6.20M$7.09M5.01%+$884.5K
CRISPR Therapeutics AG(CRSP)148,831148,8310$7.80M$7.08M5.01%-$724.8K
Skye Bioscience, Inc.(SKYE)2,007,7042,007,7040$1.51M$1.23M0.87%-$271.2K
Tempest Therapeutics, Inc.(TPST)269,772269,7720$774.2K$442.4K0.31%-$331.8K
Page 1 of 1
Versant Venture Management, LLC — 13F Holdings — Q1 2026 | TickerTrail